Study on Bioequivalence of Cefdinir Capsules in Chinese Healthy Volunteers
10.3870/j.issn.1004-0781.2015.10.006
- VernacularTitle:头孢地尼胶囊在健康人体的生物等效性研究
- Author:
Fen CHEN
;
Chaoran ZHU
;
Xuejia ZHAI
;
Xia FENG
;
Guiping DENG
;
Qing GUO
;
Lifen JIANG
;
Yongning LYU
- Publication Type:Journal Article
- Keywords:
Cefdinir capsules;
Liquid chromatography-tandem mass spectrometry;
Pharmacokinetics;
Bioequivalence
- From:
Herald of Medicine
2015;(10):1288-1291
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate postprandial pharmacokinetics and bioequivalence of two preparations of cefdinir capsules in Chinese healthy volunteers. Methods In a two-way cross-over study, 24 healthy male volunteers were divided into two groups randomly and a single dose of cefdinir capsules of test and reference preparation were administered orally, respectively.The concentration in plasma was determined by LC-MS/MS. Pharmacokinetic parameters and bioequivalence were calculated and evaluated by DAS. Results The main pharmacokinetic parameters of test and reference were as follows: AUCt (4.35±1.09) μg??h??mL-1 and (4.12±1.22) μg??h??mL-1, AUC0-∞(4.53±1.12) and (4.53±1.73) μg??h??mL-1, t1/2 (1.74±0.29) h and (2.13±1.65) h, tmax(4.44±0.86) h and (4.54 ±1.16) h, Cmax(900±250) ng??mL-1 and (876±269) ng??mL-1 . Conclusion The test and reference preparation of cefdinir capsules are bioequivalent.